Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
News Alert: FDA highlights safety issue with leadless pacemakers
Thursday, November 18, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

News Alert

FDA highlights safety issue with leadless pacemakers, focusing on Medtronic’s Micra

All pacemakers are associated with a risk of cardiac perforation, the agency said, but perforation-related complications appear to be more severe with leadless pacing systems.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

FDA highlights safety issue with leadless pacemakers, focusing on Medtronic’s Micra

Share on Twitter Share on Facebook Share on Linkedin
All pacemakers are associated with a risk of cardiac perforation, the agency said, but perforation-related complications appear to be more severe with leadless pacing systems.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

CMS to cover cardiac ablations performed in ASCs | FDA clears TAVR guidewire | A new way to repair 2 heart valves at once
News Alert: CMS to cover cardiac ablations performed in ambulatory surgical centers
The first heart device of its kind | Stem cell patch impresses | FDA sees promise in new therapy | MAC linked to major risks
Medtronic beats expectations | GLP-1 drugs & stroke | Historic hospital pauses transplant program | Boston Scientific & Epic
Week in Review: Myval TAVR valve's strong performance | Drones deliver AEDs | Did Boston Scientific make the right call?
AI flags high-risk coronary plaques | Siemens Healthineers & Boston Scientific work together | FDA clears new software
FDA clears smart shirt | Did Boston Scientific make the right call on TAVR? | Progress for heart failure drug | Beta-blockers

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …41
    • Page 42
    • Page 43
    • Page 44
    • Current page 45
    • Page 46
    • Page 47
    • Page 48
    • Page 49 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme